Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: E9ATC4
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 22 |
GO:0016740 | transferase activity | 2 | 22 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.565 |
CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.487 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.433 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.551 |
CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.493 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.435 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.432 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.452 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.406 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.499 |
DEG_SCF_TRCP1_1 | 148 | 153 | PF00400 | 0.188 |
DOC_CKS1_1 | 214 | 219 | PF01111 | 0.317 |
DOC_MAPK_gen_1 | 68 | 77 | PF00069 | 0.227 |
DOC_PP2B_LxvP_1 | 268 | 271 | PF13499 | 0.389 |
DOC_USP7_MATH_1 | 156 | 160 | PF00917 | 0.224 |
DOC_WW_Pin1_4 | 150 | 155 | PF00397 | 0.234 |
DOC_WW_Pin1_4 | 213 | 218 | PF00397 | 0.317 |
LIG_14-3-3_CanoR_1 | 14 | 19 | PF00244 | 0.398 |
LIG_14-3-3_CanoR_1 | 168 | 174 | PF00244 | 0.347 |
LIG_14-3-3_CanoR_1 | 2 | 6 | PF00244 | 0.525 |
LIG_14-3-3_CanoR_1 | 222 | 232 | PF00244 | 0.379 |
LIG_14-3-3_CanoR_1 | 32 | 39 | PF00244 | 0.176 |
LIG_14-3-3_CanoR_1 | 70 | 77 | PF00244 | 0.351 |
LIG_BRCT_BRCA1_1 | 12 | 16 | PF00533 | 0.492 |
LIG_BRCT_BRCA1_1 | 158 | 162 | PF00533 | 0.387 |
LIG_FHA_1 | 1 | 7 | PF00498 | 0.496 |
LIG_FHA_1 | 229 | 235 | PF00498 | 0.269 |
LIG_FHA_1 | 237 | 243 | PF00498 | 0.291 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.323 |
LIG_FHA_2 | 140 | 146 | PF00498 | 0.234 |
LIG_LIR_Gen_1 | 176 | 185 | PF02991 | 0.260 |
LIG_LIR_Gen_1 | 31 | 41 | PF02991 | 0.291 |
LIG_LIR_Nem_3 | 176 | 180 | PF02991 | 0.258 |
LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.302 |
LIG_Pex14_1 | 177 | 181 | PF04695 | 0.244 |
LIG_SH2_STAT3 | 266 | 269 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.252 |
LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.220 |
LIG_SH2_STAT5 | 266 | 269 | PF00017 | 0.342 |
LIG_SH3_3 | 155 | 161 | PF00018 | 0.376 |
LIG_SH3_3 | 239 | 245 | PF00018 | 0.479 |
LIG_SH3_3 | 257 | 263 | PF00018 | 0.356 |
LIG_TRFH_1 | 266 | 270 | PF08558 | 0.375 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.351 |
MOD_CK1_1 | 146 | 152 | PF00069 | 0.312 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.334 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.434 |
MOD_GlcNHglycan | 147 | 151 | PF01048 | 0.566 |
MOD_GlcNHglycan | 182 | 185 | PF01048 | 0.480 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.580 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.553 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.390 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.385 |
MOD_GSK3_1 | 180 | 187 | PF00069 | 0.263 |
MOD_N-GLC_1 | 118 | 123 | PF02516 | 0.434 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.467 |
MOD_NEK2_1 | 223 | 228 | PF00069 | 0.273 |
MOD_PK_1 | 169 | 175 | PF00069 | 0.234 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.523 |
MOD_PKA_2 | 207 | 213 | PF00069 | 0.259 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.242 |
MOD_PKB_1 | 68 | 76 | PF00069 | 0.157 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.269 |
MOD_Plk_2-3 | 139 | 145 | PF00069 | 0.234 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.573 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.208 |
MOD_ProDKin_1 | 150 | 156 | PF00069 | 0.234 |
MOD_ProDKin_1 | 213 | 219 | PF00069 | 0.317 |
TRG_DiLeu_BaLyEn_6 | 219 | 224 | PF01217 | 0.270 |
TRG_ER_diArg_1 | 168 | 170 | PF00400 | 0.363 |
TRG_ER_diArg_1 | 221 | 223 | PF00400 | 0.287 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.235 |
TRG_ER_diArg_1 | 68 | 71 | PF00400 | 0.336 |
TRG_ER_diArg_1 | 77 | 79 | PF00400 | 0.305 |
TRG_Pf-PMV_PEXEL_1 | 78 | 82 | PF00026 | 0.455 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P896 | Leptomonas seymouri | 34% | 100% |
A0A0N1PCD6 | Leptomonas seymouri | 62% | 99% |
A0A0S4IK22 | Bodo saltans | 32% | 100% |
A0A1X0NN04 | Trypanosomatidae | 32% | 100% |
A0A1X0P3F1 | Trypanosomatidae | 43% | 83% |
A0A3Q8I9N9 | Leishmania donovani | 32% | 100% |
A0A3R7K9Z6 | Trypanosoma rangeli | 48% | 95% |
A0A3R7MES7 | Trypanosoma rangeli | 33% | 100% |
A0A3S7XB94 | Leishmania donovani | 94% | 100% |
A4H781 | Leishmania braziliensis | 31% | 100% |
A4HPL2 | Leishmania braziliensis | 87% | 100% |
A4HVM1 | Leishmania infantum | 32% | 100% |
A4ID52 | Leishmania infantum | 94% | 100% |
D0A6N3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 80% |
D0A8K2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 93% |
E9APB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
Q4Q173 | Leishmania major | 93% | 100% |
Q4QG61 | Leishmania major | 32% | 100% |
V5BK55 | Trypanosoma cruzi | 33% | 100% |
V5BS52 | Trypanosoma cruzi | 49% | 94% |